Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
35.04
+0.79 (2.31%)
At close: Jul 30, 2026, 4:00 PM EDT
35.03
-0.01 (-0.03%)
After-hours: Jul 30, 2026, 7:43 PM EDT
Pulse Biosciences Revenue
Pulse Biosciences had revenue of $401.00K in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $751.00K. In the year 2025, Pulse Biosciences had annual revenue of $350.00K.
Revenue (ttm)
$751.00K
Revenue Growth
n/a
P/S Ratio
3,229.17
Revenue / Employee
$6,474
Employees
116
Market Cap
2.43B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 350.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 700.00K | -718.00K | -50.63% |
| Dec 31, 2021 | 1.42M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.68B |
| Envista Holdings | 2.81B |
| ICU Medical | 2.16B |
| Merit Medical Systems | 1.54B |
| Warby Parker | 890.57M |
| Azenta | 596.48M |
| AtriCure | 569.62M |
| STAAR Surgical Company | 290.38M |
PLSE News
- 7 hours ago - Pulse Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference - Business Wire
- 1 day ago - Pulse Biosciences surpasses enrollment midpoint in NANOPULSE-AF study - TheFly
- 1 day ago - Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study - Business Wire
- 2 days ago - Pulse Biosciences price target raised to $35 from $30 at Oppenheimer - TheFly
- 9 days ago - Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026 - Business Wire
- 15 days ago - Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 7 weeks ago - Pulse Biosciences Transcript: AGM 2026 - Transcripts
- 7 weeks ago - Pulse Biosciences Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts